BlueLine Partners

Angeion restructures board to quell proxy fight with investor

Troubled diagnostic systems maker Angeion Corp. (NASDAQ: ANGN) has restructured its board of directors to quell a proxy fight with activist shareholder BlueLine Partners LLC. Danville, California-based BlueLine Partners, which owns 7.2 percent of Angeion's outstanding shares, was gathering shareholder signatures in an effort to remove Angeion's directors --whose "advice and consent" style of corporate governance is failing to turn around the company -- and replace them with a new board nominated by shareholders.

By Mary Vanac

Devices & Diagnostics

Angeion shareholder blasts company, wants to oust board

A shareholder of struggling Angeion Corp. (Nasdaq: ANGN) blasted the company for poor performance and seeks to rally other shareholders in an effort to oust the Minnesota device company’s board. Danville, California-based BlueLine Partners, which owns 7.2 percent of Angeion’s outstanding shares, is attempting to gather signatures from other shareholders in an effort to remove […]

By Brandon Glenn

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.